Valeant, a new business model and now, a new name
Valeant Pharmaceuticals, which came under heavy scrutiny for acquiring the rights to drugs and then drastically raising their prices, is changing its name.
Tuesday, May 8, 2018
Valeant, a new business model and now, a new name
Valeant, a new business model and now, a new name
Valeant Pharmaceuticals, which came under heavy scrutiny for acquiring the rights to drugs and then drastically raising their prices, is changing its name.
Related Posts:
Lyft valued at $24.3 billion in first ride-hailing IPO- Global M&A slides in first quarter as Brexit weighs on Europe
- GM to sell closed South Korean plant to local parts maker for $99 million
- China's Huawei posts 25 percent rise in 2018 profit on smartphone sales
- Asian stocks gain on hopes of progress in U.S.-China trade talks
0 comments:
Post a Comment